Burlingame, CA, April 21, 2025 (GLOBE NEWSWIRE) — Coherent Market Insights published a report, titled, the global Surface Plasmon Resonance Market size is estimated to grow from US$ 1,107.0 Million in 2025 and is forecast to reach a value of US$ 1,720.3 Million by 2032 at a CAGR of 6.5% between 2025 and 2032.
Request a Sample of the US Tariff Impact Analysis Report: https://www.coherentmarketinsights.com/insight/request-sample/3283
Global Surface Plasmon Resonance Market Key Takeaways
The global surface plasmon resonance market size is projected to grow from USD 1,107 million in 2025 to USD 1,720.3 million by 2032, exhibiting a CAGR of 6.5% during the assessment period.
By product type, sensor system segment is set to account for a prominent global surface plasmon resonance market share in 2025.
Based on application, drug discovery segment will likely retain its market dominance during the forecast period. This can be attributed to increasing usage of surface plasmon resonance (SPR) in the field of drug discovery.
North America leads from the forefront when it comes to surface plasmon resonance market demand. The region is expected to account for a dominant market share of 45.1% in 2025.
Latin America accounts for the second-largest market share, as per Coherent Market Insights’ latest surface plasmon resonance market research.
Asia Pacific will likely record strong growth during the assessment period, owing to rising prevalence of chronic and infectious diseases and expanding usage of SPR in clinical diagnostics.
Increasing Drug Discovery and Development Activities Fueling Market Growth
A new report by Coherent Market Insights outlines significant surface plasmon resonance market growth factors. One major growth factor is the increasing drug discovery and development activities globally.
The pharmaceutical industry is constantly striving to develop innovative treatments for various diseases. This is expected to fuel demand for surface plasmon resonance systems during the forecast period.
Surface plasmon resonance technology has become an ideal tool in early-stage drug screening, lead identification, and characterization of kinetics. This is due to its tendency to offer real-time, label-free analysis of biomolecular interactions. Rising emphasis on drug discovery and development activities is expected to foster surface plasmon resonance market growth.
Buy this Complete Report (PDF with Insights, Charts, Tables, and Figures) at: https://www.coherentmarketinsights.com/insight/buy-now/3283
High Equipment Costs and Lack of Skilled Professionals Limited Growth
Despite a positive growth trajectory, certain factors are limiting the surface …